During this time of thanksgiving, we are so grateful that the large majority of schools are fully opened for in-school experiences. As yet another step in providing a safe in-school experience for students, children ages 5 to 11 are now eligible to receive vaccinations specifically formulated for young children. With that in mind, it is the goal of NAFSCE and the U.S. Department of Ed provide parents and practitioners with the latest research and information so parents are able to make the best decision they can around vaccinating their children. This webinar is a unique opportunity for parents and family engagement practitioners to ask questions, share their ideas and concerns, and to get their questions answered.

Please join NAFSCE and the U.S. Department of Education on December 9 at 8:00pm, ET for an informational webinar following the official approval of the Pfizer-BioNTech age 5-11 vaccine. During the webinar, panelists including United States Deputy Secretary of Education Cindy Marten, along with representatives from the Centers for Disease Control and Prevention and the American Academy of Pediatrics, will join NAFSCE Executive Director, Vito Borrello for a series of presentations and constructive conversation to support parents and families as they consider the COVID-19 vaccine for their child(ren).

● How was the vaccine developed?
● How many children participated in the study for approval?
● Will my child(ren) be safe taking the vaccine?
● What are the side effects?
● Should my child(ren) get the vaccine?
● Where can I take my child to get the vaccine?

Parents are invited to submit questions about the vaccine on the registration form. Pre-submitted questions will help plan the content of the session. Time will also be reserved for live questions and answers at the end of the event.